Pfizer’s battle over the safety label for its birth control injection has finally come to a close. The pharma giant announced that the Food and Drug Administration approved its new safety warning ...
The study will examine vaccine safety, efficacy and immunity at lower doses. Pfizer is advancing Phase 2/3 clinical trials for young kids at lower doses than vaccines for adults, the pharmaceutical ...
U.S. health regulators posted a positive review of Pfizer's COVID-19 vaccine as they near a decision on whether to allow use of the shot. The review posted online Tuesday by the Food and Drug ...
Pfizer announced Wednesday that its COVID-19 vaccine is safe and strongly protective in kids as young as 12, a step toward possibly beginning shots in this age group before they head back to school in ...
Hosted on MSN
Pfizer's Covid-19 vaccine availability for children under 5 faces potential FDA roadblock
As Autumn rolls around, parents in the US who want to vaccinate their young children against COVID-19 may find it trickier to do so this year. According to the US Centres for Disease Control and ...
Pfizer Inc (PFE) announced an update on their ongoing clinical study.
Considerable on MSN
Pfizer channels COVID windfall into cancer
Pfizer is steering much of its pandemic revenue into oncology, as Chief Executive Albert ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results